… interleukin-13 (IL-13) were produced following activation of peripheral blood effector CD8+
T cells from SSc patients as compared with normal controls or with patients … IL-13 production. …

… In the total patient … IL13 polymorphisms, IL13 rs1800925 (IL13-1055), and IL13 rs2243204,
and disease (p=0.03–0.04). The IL13 rs2243204T allele was more common in SSc patients (p…

… levels are elevated both in the blood and in the skin of patients. This review will examine
the role of IL-13 in driving fibrosis with a particular emphasis on systemic sclerosis as a …

… interleukin-13 (IL-13) production by peripheral blood effector CD8+ T cells from SSc patients
… The present study was undertaken to investigate the role of IL-13 production by CD8+ T …

… Levels of IL-4, IL-13 and CXCL4 are higher in the serum of SSc patients compared to … IL-4
prevents skin sclerosis. In SSc, CD8+ T lymphocytes secrete IL-13 and mediate dermal fibrosis …

… to investigate whether interleukin-13 (IL-13) serum levels correlate to different nailfold
capillaroscopy (NC) findings in patients with systemic sclerosis (SSc). IL-13 serum levels were …

… (TGF)-β and interleukin (IL)-13 play a crucial role in the pathogenesis of systemic sclerosis
(SSc), … TFG-β alters IL-13 production in T lymphocytes from patients with SSc from that seen in …

… of 13 versus 2 of 8, P < 0.01). IL-13 protein was detectable in the BALF of 8 of 13 patients with
… AMs of four subjects with systemic sclerosis were cultured and IL-13 protein was increased …

… in the genes encoding interleukin 4 (IL4), interleukin 13 (IL13), … previous observations in
patients with systemic sclerosis (SSc… We genotyped a cohort of 2488 patients with SSc and 2246 …

… Despite the importance of interleukin-13 (IL-13) in systemic sclerosis (SSc) and other fibrotic
… of interleukin-13 (IL-13) by peripheral blood effector CD8+ T cells is present in patients with …